Buona Fortuna Medical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -28.73%
- Profit Growth -65.44%
- Ebitda -28.43%
- Net Worth 35.01%
- Total Assets -19.22%
About Buona Fortuna Medical
Buona Fortuna Medical Private Limited (BFMPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 2011 and has a history of 13 years and six months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shivanand Karopadi, Sadhana Sundaram, and Akash Karopadi serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85190TG2011PTC075706
-
Company No.
075706
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jul 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Buona Fortuna Medical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivanand Karopadi
|
Whole-Time Director | 28-Jul-2011 | Current |
|
Sadhana Sundaram
|
Whole-Time Director | 28-Jul-2011 | Current |
|
Akash Karopadi
|
Director | 19-Jan-2015 | Current |
Financial Performance of Buona Fortuna Medical.
Buona Fortuna Medical Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 28.73% decrease. The company also saw a substantial fall in profitability, with a 65.44% decrease in profit. The company's net worth Soared by an impressive increase of 35.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Buona Fortuna Medical?
In 2017, Buona Fortuna Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vivo Bio Tech LimitedShivanand Karopadi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Buona Fortuna Medical?
Unlock and access historical data on people associated with Buona Fortuna Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Buona Fortuna Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Buona Fortuna Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.